Innovative Industrial Properties Reports Fourth Quarter and Full-Year 2024 Results
Innovative Industrial Properties (NYSE: IIPR) reported its Q4 and full-year 2024 results, showing total revenues of $308.5 million for the year and $76.7 million for Q4. The company's net income attributable to common stockholders was $159.9 million ($5.52 per share) for 2024, with AFFO of $256.1 million ($8.98 per share).
Key highlights include: leasing activity of 530,000 square feet (6% of total portfolio), commitment of over $70 million for property acquisitions and improvements, and increased revolving credit facility capacity to $87.5 million. The portfolio totals $2.5 billion of invested/committed capital across 109 properties in 19 states.
Notable developments include the resolution with PharmaCann, involving lease amendments for nine properties reducing monthly base rent from $2.8M to $2.6M, and plans to transition two cultivation properties in Michigan and Massachusetts to new tenants. The company maintained its dividend increase streak since 2016, declaring $7.52 per share for 2024.
Innovative Industrial Properties (NYSE: IIPR) ha riportato i risultati del quarto trimestre e dell'intero anno 2024, mostrando ricavi totali di 308,5 milioni di dollari per l'anno e 76,7 milioni di dollari per il quarto trimestre. Il reddito netto attribuibile agli azionisti ordinari è stato di 159,9 milioni di dollari (5,52 dollari per azione) per il 2024, con un AFFO di 256,1 milioni di dollari (8,98 dollari per azione).
I punti salienti includono: attività di locazione di 530.000 piedi quadrati (6% del portafoglio totale), impegno di oltre 70 milioni di dollari per acquisizioni e miglioramenti immobiliari, e aumento della capacità della linea di credito revolving a 87,5 milioni di dollari. Il portafoglio totale ammonta a 2,5 miliardi di dollari di capitale investito/impegnato su 109 proprietà in 19 stati.
Sviluppi notevoli includono la risoluzione con PharmaCann, che comporta emendamenti al contratto di locazione per nove proprietà riducendo l'affitto base mensile da 2,8 milioni di dollari a 2,6 milioni di dollari, e piani per trasferire due proprietà di coltivazione nel Michigan e nel Massachusetts a nuovi inquilini. L'azienda ha mantenuto la sua serie di aumenti dei dividendi dal 2016, dichiarando 7,52 dollari per azione per il 2024.
Innovative Industrial Properties (NYSE: IIPR) reportó sus resultados del cuarto trimestre y del año completo 2024, mostrando ingresos totales de 308.5 millones de dólares para el año y 76.7 millones de dólares para el cuarto trimestre. El ingreso neto atribuible a los accionistas comunes fue de 159.9 millones de dólares (5.52 dólares por acción) para 2024, con un AFFO de 256.1 millones de dólares (8.98 dólares por acción).
Los aspectos destacados incluyen: actividad de arrendamiento de 530,000 pies cuadrados (6% del portafolio total), compromiso de más de 70 millones de dólares para adquisiciones y mejoras de propiedades, y aumento de la capacidad de la línea de crédito rotativo a 87.5 millones de dólares. El portafolio totaliza 2.5 mil millones de dólares de capital invertido/comprometido en 109 propiedades en 19 estados.
Desarrollos notables incluyen la resolución con PharmaCann, que implica enmiendas de arrendamiento para nueve propiedades reduciendo el alquiler base mensual de 2.8 millones de dólares a 2.6 millones de dólares, y planes para transferir dos propiedades de cultivo en Michigan y Massachusetts a nuevos inquilinos. La empresa ha mantenido su racha de aumento de dividendos desde 2016, declarando 7.52 dólares por acción para 2024.
Innovative Industrial Properties (NYSE: IIPR)는 2024년 4분기 및 연간 실적을 보고하며, 연간 총 수익이 3억 8천5백만 달러, 4분기 수익이 7천6백7십만 달러에 달했다고 발표했습니다. 회사의 일반 주주에게 귀속되는 순이익은 2024년에 1억 5천9백9십만 달러(주당 5.52달러)였으며, AFFO는 2억 5천6백1십만 달러(주당 8.98달러)였습니다.
주요 하이라이트로는: 53만 평방피트(전체 포트폴리오의 6%)의 임대 활동, 7천만 달러 이상의 부동산 인수 및 개선에 대한 약속, 그리고 회전 신용 시설 용량을 8천7백5십만 달러로 증가시킨 것이 포함됩니다. 포트폴리오는 19개 주에 걸쳐 109개의 자산에 대해 25억 달러의 투자/약정 자본을 포함하고 있습니다.
주목할 만한 발전으로는 PharmaCann과의 합의가 있으며, 이는 9개 자산에 대한 임대 수정으로 월 기본 임대료를 280만 달러에서 260만 달러로 줄이는 것과, 미시간 및 매사추세츠의 두 개의 재배 자산을 새로운 임차인으로 이전할 계획이 포함됩니다. 회사는 2016년 이후 배당금 인상 기록을 유지하며, 2024년에는 주당 7.52달러를 선언했습니다.
Innovative Industrial Properties (NYSE: IIPR) a annoncé ses résultats du quatrième trimestre et de l'année 2024, affichant des revenus totaux de 308,5 millions de dollars pour l'année et de 76,7 millions de dollars pour le quatrième trimestre. Le bénéfice net attribuable aux actionnaires ordinaires s'est élevé à 159,9 millions de dollars (5,52 dollars par action) pour 2024, avec un AFFO de 256,1 millions de dollars (8,98 dollars par action).
Les points clés incluent : une activité de location de 530 000 pieds carrés (6 % du portefeuille total), un engagement de plus de 70 millions de dollars pour des acquisitions et améliorations immobilières, et une augmentation de la capacité de la ligne de crédit renouvelable à 87,5 millions de dollars. Le portefeuille totalise 2,5 milliards de dollars de capital investi/engagé dans 109 propriétés dans 19 États.
Les développements notables incluent la résolution avec PharmaCann, impliquant des modifications de bail pour neuf propriétés, réduisant le loyer de base mensuel de 2,8 millions de dollars à 2,6 millions de dollars, ainsi que des plans pour transférer deux propriétés de culture au Michigan et au Massachusetts à de nouveaux locataires. L'entreprise a maintenu sa série d'augmentations de dividendes depuis 2016, déclarant 7,52 dollars par action pour 2024.
Innovative Industrial Properties (NYSE: IIPR) hat seine Ergebnisse für das vierte Quartal und das Gesamtjahr 2024 veröffentlicht, die Gesamteinnahmen von 308,5 Millionen Dollar für das Jahr und 76,7 Millionen Dollar für das vierte Quartal zeigen. Das Nettogewinn, das den Stammaktionären zuzurechnen ist, betrug 159,9 Millionen Dollar (5,52 Dollar pro Aktie) für 2024, mit einem AFFO von 256,1 Millionen Dollar (8,98 Dollar pro Aktie).
Wichtige Highlights sind: Vermietungsaktivitäten von 530.000 Quadratfuß (6% des Gesamtportfolios), Engagement von über 70 Millionen Dollar für Immobilienakquisitionen und -verbesserungen sowie die Erhöhung der revolvierenden Kreditlinienkapazität auf 87,5 Millionen Dollar. Das Portfolio umfasst insgesamt 2,5 Milliarden Dollar an investiertem/engagiertem Kapital über 109 Immobilien in 19 Bundesstaaten.
Bemerkenswerte Entwicklungen umfassen die Einigung mit PharmaCann, die Mietänderungen für neun Immobilien beinhaltet, wobei die monatliche Grundmiete von 2,8 Millionen Dollar auf 2,6 Millionen Dollar gesenkt wird, sowie Pläne zur Übergabe von zwei Anbauimmobilien in Michigan und Massachusetts an neue Mieter. Das Unternehmen hat seine Dividendensteigerung seit 2016 fortgesetzt und für 2024 7,52 Dollar pro Aktie erklärt.
- Portfolio expansion with 109 properties across 19 states totaling $2.5 billion invested capital
- Strong AFFO of $256.1 million ($8.98 per share) for 2024
- High operating portfolio occupancy rate of 98.3%
- Improved liquidity with increased credit facility to $87.5 million
- Strong balance sheet with only 11% debt to total gross assets
- Continued dividend growth, maintaining increase streak since 2016
- Q4 revenue declined 3% year-over-year to $76.7 million
- Full-year revenue decreased slightly to $308.5 million from $309.5 million in 2023
- PharmaCann lease defaults requiring restructuring and rent reductions
- Security deposits applied for rent payments from five tenants in Q4 2024
Insights
The financial results reveal both resilience and challenges in IIPR's business model. The marginal
The debt service coverage ratio of 16.8x demonstrates exceptional financial health, significantly exceeding typical REIT industry standards of 2-3x. This, combined with the low 11% debt to total gross assets ratio, positions IIPR well to weather industry volatility and potential tenant challenges.
The PharmaCann resolution represents a strategic compromise, reducing monthly base rent from
Portfolio metrics reveal prudent diversification: no tenant exceeds
The AFFO of
The expansion of the revolving credit facility to
2024 Leasing Activity of 530,000 Square Feet, or
Full Year 2024
-
Total revenues of
.$308.5 million -
Net income attributable to common stockholders of
, or$159.9 million per share (all per share amounts in this press release are reported on a diluted basis unless otherwise noted).$5.52 -
Adjusted funds from operations (AFFO) of
, or$256.1 million per share, and normalized funds from operations (Normalized FFO) of$8.98 , or$231.0 million per share.$8.10 -
Declared dividends to common stockholders totaling
per share, increasing IIP’s common stock dividends declared each year since its inception in 2016.$7.52 -
Committed over
for the payment of purchase prices and funding of qualifying building infrastructure improvements for two property acquisitions and lease amendments for three properties.$70 million -
Released 530,000 square feet totaling ~
6% of the total portfolio’s rentable square feet. -
Improved liquidity by increasing IIP’s revolving credit facility capacity from
at December 31, 2023 to$30.0 million at December 31, 2024.$87.5 million -
At year-end, IIP’s portfolio totaled
of invested / committed capital and was comprised of 109 properties totaling 9 million rentable square feet in 19 states.$2.5 billion
Years Ended December 31, |
|||||||
(Per share) |
2024 |
|
2023 |
|
$ Change |
|
% Change |
Net income attributable to common stockholders |
|
|
( |
( |
|||
Normalized FFO |
|
|
( |
( |
|||
AFFO |
|
|
( |
( |
Fourth Quarter 2024
Financial Results and Dividend
-
Total revenues of
for the quarter.$76.7 million -
Net income attributable to common stockholders of
for the quarter, or$39.5 million per share.$1.36 -
AFFO of
, or$63.4 million per share.$2.22 -
Paid a quarterly dividend of
per common share on January 15, 2025 to stockholders of record as of December 31, 2024.$1.90
Three Months Ended December 31, |
|||||||
(Per share) |
2024 |
|
2023 |
|
$ Change |
|
% Change |
Net income attributable to common stockholders |
|
|
( |
( |
|||
Normalized FFO |
|
|
( |
( |
|||
AFFO |
|
|
( |
( |
Financing Activity
-
In November, upsized IIP’s revolving credit facility from
to$50.0 million , which remains undrawn as of today.$87.5 million
Balance Sheet Highlights (at December 31, 2024)
-
11% debt to total gross assets, with in total gross assets.$2.6 billion -
Total liquidity was
as of December 31, 2024, consisting of cash and cash equivalents and short-term investments (each as reported in IIP’s consolidated balance sheet as of December 31, 2024) and availability under IIP’s revolving credit facility.$238.7 million - No debt maturities until May 2026.
-
Debt service coverage ratio of 16.8x (calculated in accordance with IIP’s
5.50% Unsecured Senior Notes due 2026).
Portfolio – New Investment, Leasing and Development
-
In October, acquired a 23,000 square foot
Maryland property for and executed a long-term lease with a subsidiary of Maryland Cultivation and Processing, L.L.C. (MCP) for use as a regulated cannabis processing facility.$5.6 million -
In November, leased 160,000 square feet at IIP’s New Beaver Avenue property in
Pittsburgh, Pennsylvania to Tri-Mountain Pure, a licensedPennsylvania grower-processor. -
In November, leased 6,000 square feet at IIP’s North Anza Road and Del Sol Road property in
Palm Springs, California to a non-cannabis tenant.
Property Portfolio Statistics (as of December 31, 2024)
-
Total property portfolio comprises 109 properties across 19 states, with 9.0 million RSF (including 666,000 RSF under development / redevelopment), consisting of:
- Operating portfolio: 106 properties, representing 8.5 million RSF.
-
Under development / redevelopment portfolio consists of three properties expected to comprise 491,000 RSF at completion and are as follows:
-
236,000 square feet located at 63795 19th Avenue in
Palm Springs, California (pre-leased) -
192,000 square feet located at Inland Center Drive in
San Bernardino, California -
12-acre development site located at Leah Avenue in
San Marcos, Texas
-
236,000 square feet located at 63795 19th Avenue in
-
Operating portfolio:
-
98.3% leased. - Weighted-average remaining lease term: 13.7 years.
-
Total invested / committed capital per square foot:
.$281
-
-
By annualized base rent (excluding non-cannabis tenants that comprise less than
1% of annualized base rent in the aggregate):-
No tenant represents more than
17% of annualized base rent. -
No state represents more than
15% of annualized base rent. -
Multi-state operators (MSOs) represent
90% of annualized base rent. -
Public company operators represent
62% of annualized base rent. -
Industrial (cultivation and/or processing), retail (dispensing) and combined industrial/retail represent
92% ,2% and6% of the operating portfolio, respectively.
-
No tenant represents more than
Year-to-Date 2025
Investment Activity
-
Under contract for a 20,000 square foot
Maryland property for . Closing remains subject to diligence and closing conditions.$7.8 million
Senior Leadership Promotions
- In January, Tracie Hager was appointed Senior Vice President, Asset Management after previously serving as Vice President, Asset Management. Ms. Hager has been with the company since October 2019.
- In January, Kelly Spicher was appointed Senior Vice President, Real Estate Counsel after previously serving as Vice President, Real Estate Counsel. Ms. Spicher has been with the company since September 2019.
PharmaCann Resolution
-
As previously reported on January 30, 2025, IIP reached an agreement to resolve the existing lease defaults with PharmaCann Inc. and its affiliates (“PharmaCann”) under leases for eleven properties that the Company owns. Key terms of the agreement between PharmaCann and IIP are as follows:
- Fully utilized security deposits to cover the defaulted rent in full for December 2024 and January 2025, along with certain penalties.
-
Amended leases for nine properties located in
New York ,Illinois ,Pennsylvania ,Ohio andColorado by reducing cumulative total base rent from per month to$2.8 million per month, with cash rent payments commencing February 1, 2025. Total required security deposits were also increased.$2.6 million -
PharmaCann will work with IIP to transition two cultivation properties in
Michigan andMassachusetts to new tenant(s) by contributing the licenses, subject to regulatory requirements, and providing other support as requested by IIP. If the properties have not been transitioned to new tenant(s) by August 1, 2025, IIP will regain full control and PharmaCann will have no further obligations under the Leases for these properties. Monthly base rent of will be abated in full effective February 1, 2025.$1.3 million -
In consideration for IIP entering into these amendments:
- Additional equity capital is being contributed to PharmaCann by certain of PharmaCann’s current investors
- PharmaCann issued an interest-bearing, secured promissory note to IIP (the “Note”), which matures February 1, 2035 (or earlier upon a change of control or certain other events). The Note is junior to PharmaCann's existing senior secured facility and is secured by all of PharmaCann’s assets, including licenses, where allowed by law.
- PharmaCann agreed that, except for refinancing the existing senior secured credit facility and the additional equity investments, it may not incur additional indebtedness without IIP’s consent until full repayment of the Note or its cancellation.
- If PharmaCann is not able to refinance its existing senior secured credit facility maturing June 30, 2025, all modifications to the Leases described herein will immediately be null and void and the Leases will revert to the terms in effect as of January 1, 2025 and the Note will be cancelled.
Select Financial Results
For the three months ended December 31, 2024, IIP generated total revenues of
For the three months ended December 31, 2024, IIP applied
While IIP has re-leased several properties that we regained possession of, the rent commencement on certain of these properties is contingent on the tenants obtaining the requisite approvals to operate. IIP has also granted temporary rent abatements in certain instances as tenants transition into the properties and commence operations. As a result, IIP does not expect to recognize rental revenue from those properties until such events have occurred.
For the year ended December 31, 2024, IIP generated total revenues of
IIP paid a quarterly dividend of
Supplemental Information
Supplemental financial information is available in the Investor Relations section of IIP’s website at www.innovativeindustrialproperties.com.
Teleconference and Webcast
Innovative Industrial Properties, Inc. will conduct a conference call and webcast at 9:00 a.m. Pacific Time (12:00 p.m. Eastern Time) on Thursday, February 20, 2025 to discuss IIP’s financial results and operations for the year ended December 31, 2024. The call will be open to all interested investors through a live audio webcast at the Investor Relations section of IIP’s website at www.innovativeindustrialproperties.com, or live by calling 1 (877) 328-5514 (domestic) or 1 (412) 902-6764 (international) and asking to be joined to the Innovative Industrial Properties, Inc. conference call. The complete webcast will be archived for 90 days on IIP’s website. A telephone playback of the conference call will also be available from 12:00 p.m. Pacific Time on Thursday, February 20, 2025 until 12:00 p.m. Pacific Time on Thursday, February 27, 2025, by calling 1 (877) 344-7529 (domestic), 855-669-9658 (
About Innovative Industrial Properties
Innovative Industrial Properties, Inc. is a real estate investment trust (REIT) focused on the acquisition, ownership and management of specialized industrial properties leased to experienced, state-licensed operators for their regulated cannabis facilities. Additional information is available at www.innovativeindustrialproperties.com.
This press release contains statements that IIP believes to be “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than historical facts are forward-looking statements. When used in this press release, words such as IIP “expects,” “intends,” “plans,” “estimates,” “anticipates,” “believes” or “should” or the negative thereof or similar terminology are generally intended to identify forward-looking statements. Such forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in, or implied by, such statements. Investors should not place undue reliance upon forward-looking statements. IIP disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Innovative Industrial Properties, Inc. CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (In thousands, except share and per share amounts) |
||||||
|
|
|
|
|
|
|
|
|
December 31, |
|
December 31, |
||
Assets |
|
2024 |
|
2023 |
||
Real estate, at cost: |
|
|
|
|
|
|
Land |
|
$ |
146,772 |
|
$ |
142,524 |
Buildings and improvements |
|
|
2,230,807 |
|
|
2,108,218 |
Construction in progress |
|
|
62,393 |
|
|
117,773 |
Total real estate, at cost |
|
|
2,439,972 |
|
|
2,368,515 |
Less accumulated depreciation |
|
|
(271,190) |
|
|
(202,692) |
Net real estate held for investment |
|
|
2,168,782 |
|
|
2,165,823 |
Construction loan receivable |
|
|
22,800 |
|
|
22,000 |
Cash and cash equivalents |
|
|
146,245 |
|
|
140,249 |
Restricted cash |
|
|
— |
|
|
1,450 |
Investments |
|
|
5,000 |
|
|
21,948 |
Right of use office lease asset |
|
|
946 |
|
|
1,355 |
In-place lease intangible assets, net |
|
|
7,385 |
|
|
8,245 |
Other assets, net |
|
|
26,889 |
|
|
30,020 |
Total assets |
|
$ |
2,378,047 |
|
$ |
2,391,090 |
|
|
|
|
|
|
|
Liabilities and stockholders’ equity |
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
Exchangeable Senior Notes, net |
|
$ |
— |
|
$ |
4,431 |
Notes due 2026, net |
|
|
297,865 |
|
|
296,449 |
Building improvements and construction funding payable |
|
|
10,230 |
|
|
9,591 |
Accounts payable and accrued expenses |
|
|
10,561 |
|
|
11,406 |
Dividends payable |
|
|
54,817 |
|
|
51,827 |
Rent received in advance and tenant security deposits |
|
|
57,176 |
|
|
59,358 |
Other liabilities |
|
|
11,338 |
|
|
5,056 |
Total liabilities |
|
|
441,987 |
|
|
438,118 |
|
|
|
|
|
|
|
Stockholders’ equity: |
|
|
|
|
|
|
Preferred stock, par value |
|
|
23,632 |
|
|
14,009 |
Common stock, par value |
|
|
28 |
|
|
28 |
Additional paid-in capital |
|
|
2,124,113 |
|
|
2,095,789 |
Dividends in excess of earnings |
|
|
(211,713) |
|
|
(156,854) |
Total stockholders’ equity |
|
|
1,936,060 |
|
|
1,952,972 |
Total liabilities and stockholders’ equity |
|
$ |
2,378,047 |
|
$ |
2,391,090 |
INNOVATIVE INDUSTRIAL PROPERTIES, INC. CONDENSED CONSOLIDATED STATEMENTS OF INCOME For the Three Months and Years Ended December 31, 2024 and 2023 (Unaudited) (In thousands, except share and per share amounts) |
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended |
|
For the Year Ended |
||||||||
|
|
December 31, |
|
December 31, |
||||||||
|
|
2024 |
|
2023 |
|
2024 |
|
2023 |
||||
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
Rental (including tenant reimbursements) |
|
$ |
76,717 |
|
$ |
78,615 |
|
$ |
306,936 |
|
$ |
307,349 |
Other |
|
|
27 |
|
|
541 |
|
|
1,581 |
|
|
2,157 |
Total revenues |
|
|
76,744 |
|
|
79,156 |
|
|
308,517 |
|
|
309,506 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
Property expenses |
|
|
7,605 |
|
|
7,193 |
|
|
28,472 |
|
|
24,893 |
General and administrative expense |
|
|
8,891 |
|
|
10,908 |
|
|
37,444 |
|
|
42,832 |
Depreciation and amortization expense |
|
|
18,240 |
|
|
17,098 |
|
|
70,807 |
|
|
67,194 |
Total expenses |
|
|
34,736 |
|
|
35,199 |
|
|
136,723 |
|
|
134,919 |
Gain (loss) on sale of real estate |
|
|
— |
|
|
— |
|
|
(3,449) |
|
|
— |
Income from operations |
|
|
42,008 |
|
|
43,957 |
|
|
168,345 |
|
|
174,587 |
Interest income |
|
|
2,553 |
|
|
1,821 |
|
|
10,988 |
|
|
8,446 |
Interest expense |
|
|
(4,536) |
|
|
(4,145) |
|
|
(17,672) |
|
|
(17,467) |
Gain (loss) on exchange of Exchangeable Senior Notes |
|
|
— |
|
|
— |
|
|
— |
|
|
22 |
Net income |
|
|
40,025 |
|
|
41,633 |
|
|
161,661 |
|
|
165,588 |
Preferred stock dividends |
|
|
(564) |
|
|
(338) |
|
|
(1,804) |
|
|
(1,352) |
Net income attributable to common stockholders |
|
$ |
39,461 |
|
$ |
41,295 |
|
$ |
159,857 |
|
$ |
164,236 |
Net income attributable to common stockholders per share: |
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
1.38 |
|
$ |
1.46 |
|
$ |
5.58 |
|
$ |
5.82 |
Diluted |
|
$ |
1.36 |
|
$ |
1.45 |
|
$ |
5.52 |
|
$ |
5.77 |
Weighted-average shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
28,254,565 |
|
|
27,996,393 |
|
|
28,226,402 |
|
|
27,977,807 |
Diluted |
|
|
28,554,335 |
|
|
28,279,834 |
|
|
28,530,650 |
|
|
28,255,797 |
INNOVATIVE INDUSTRIAL PROPERTIES, INC. CONSOLIDATED FFO, NORMALIZED FFO AND AFFO For the Three Months and Years Ended December 31, 2024 and 2023 (Unaudited) (In thousands, except share and per share amounts) |
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended |
|
For the Year Ended |
||||||||
|
|
December 31, |
|
December 31, |
||||||||
|
|
2024 |
|
2023 |
|
2024 |
|
2023 |
||||
Net income attributable to common stockholders |
|
$ |
39,461 |
|
$ |
41,295 |
|
$ |
159,857 |
|
$ |
164,236 |
Real estate depreciation and amortization |
|
|
18,240 |
|
|
17,098 |
|
|
70,807 |
|
|
67,194 |
Disposition-contingent lease termination fee, net of loss on sale of real estate(1) |
|
|
— |
|
|
— |
|
|
(451) |
|
|
— |
FFO attributable to common stockholders (basic) |
|
|
57,701 |
|
|
58,393 |
|
|
230,213 |
|
|
231,430 |
Cash and non-cash interest expense on Exchangeable Senior Notes |
|
|
— |
|
|
50 |
|
|
28 |
|
|
219 |
FFO attributable to common stockholders (diluted) |
|
|
57,701 |
|
|
58,443 |
|
|
230,241 |
|
|
231,649 |
Litigation-related expense |
|
|
268 |
|
|
152 |
|
|
788 |
|
|
2,480 |
Loss (gain) on exchange of Exchangeable Senior Notes |
|
|
— |
|
|
— |
|
|
— |
|
|
(22) |
Normalized FFO attributable to common stockholders (diluted) |
|
|
57,969 |
|
|
58,595 |
|
|
231,029 |
|
|
234,107 |
Interest income on seller-financed note(2) |
|
|
30 |
|
|
403 |
|
|
1,104 |
|
|
1,342 |
Deferred lease payments received on sales-type leases(3) |
|
|
568 |
|
|
— |
|
|
4,938 |
|
|
— |
Stock-based compensation |
|
|
4,315 |
|
|
4,934 |
|
|
17,317 |
|
|
19,581 |
Non-cash interest expense |
|
|
456 |
|
|
383 |
|
|
1,664 |
|
|
1,375 |
Above-market lease amortization |
|
|
23 |
|
|
23 |
|
|
92 |
|
|
92 |
AFFO attributable to common stockholders (diluted) |
|
$ |
63,361 |
|
$ |
64,338 |
|
$ |
256,144 |
|
$ |
256,497 |
FFO per common share – diluted |
|
$ |
2.02 |
|
$ |
2.07 |
|
$ |
8.07 |
|
$ |
8.20 |
Normalized FFO per common share – diluted |
|
$ |
2.03 |
|
$ |
2.07 |
|
$ |
8.10 |
|
$ |
8.29 |
AFFO per common share – diluted |
|
$ |
2.22 |
|
$ |
2.28 |
|
$ |
8.98 |
|
$ |
9.08 |
Weighted average common shares outstanding – basic |
|
|
28,254,565 |
|
|
27,996,393 |
|
|
28,226,402 |
|
|
27,977,807 |
Restricted stock and RSUs |
|
|
299,770 |
|
|
206,667 |
|
|
294,780 |
|
|
196,821 |
Dilutive effect of Exchangeable Senior Notes |
|
|
— |
|
|
76,774 |
|
|
9,468 |
|
|
81,169 |
Weighted average common shares outstanding – diluted |
|
|
28,554,335 |
|
|
28,279,834 |
|
|
28,530,650 |
|
|
28,255,797 |
_________________________________________ | ||
(1) |
Amount reflects the |
|
(2) |
Amount reflects the non-refundable interest received on the seller-financed note issued to IIP by the buyer in connection with IIP’s disposition of a portfolio of four properties in southern |
|
(3) | Amount reflects the non-refundable lease payments received on two sales-type leases which are recognized as a deposit liability starting on January 1, 2024, and is included in other liabilities in IIP’s consolidated balance sheets as of December 31, 2024, as the transaction did not qualify for recognition as a completed sale. Prior to the lease modifications on January 1, 2024, which extended the initial lease terms, the leases were classified as operating leases and the lease payments received were recognized as rental revenue and therefore, included in net income attributable to common stockholders. |
FFO and FFO per share are operating performance measures adopted by the National Association of Real Estate Investment Trusts, Inc. (NAREIT). NAREIT defines FFO as the most commonly accepted and reported measure of a REIT’s operating performance equal to net income, computed in accordance with accounting principles generally accepted in
Management believes that net income, as defined by GAAP, is the most appropriate earnings measurement. However, management believes FFO and FFO per share to be supplemental measures of a REIT’s performance because they provide an understanding of the operating performance of IIP’s properties without giving effect to certain significant non-cash items, primarily depreciation expense. Historical cost accounting for real estate assets in accordance with GAAP assumes that the value of real estate assets diminishes predictably over time. However, real estate values instead have historically risen or fallen with market conditions. IIP believes that by excluding the effect of depreciation, FFO and FFO per share can facilitate comparisons of operating performance between periods. IIP reports FFO and FFO per share because these measures are observed by management to also be the predominant measures used by the REIT industry and industry analysts to evaluate REITs and because FFO per share is consistently reported, discussed, and compared by research analysts in their notes and publications about REITs. For these reasons, management has deemed it appropriate to disclose and discuss FFO and FFO per share.
IIP computes Normalized FFO by adjusting FFO to exclude certain GAAP income and expense amounts that management believes are infrequent and unusual in nature and/or not related to IIP’s core real estate operations. Exclusion of these items from similar FFO-type metrics is common within the equity REIT industry, and management believes that presentation of Normalized FFO and Normalized FFO per share provides investors with a metric to assist in their evaluation of IIP’s operating performance across multiple periods and in comparison to the operating performance of other companies, because it removes the effect of unusual items that are not expected to impact IIP’s operating performance on an ongoing basis. Normalized FFO is used by management in evaluating the performance of its core business operations. Items included in calculating FFO that may be excluded in calculating Normalized FFO include certain transaction-related gains, losses, income or expense or other non-core amounts as they occur.
Management believes that AFFO and AFFO per share are also appropriate supplemental measures of a REIT’s operating performance. IIP calculates AFFO by adjusting Normalized FFO for certain cash and non-cash items.
For all periods presented other than the three months ended December 31, 2024, FFO (diluted), Normalized FFO, AFFO and FFO, Normalized FFO and AFFO per diluted share include the dilutive impact of the assumed full exchange of the Exchangeable Senior Notes for shares of common stock.
For the three months and years ended December 31, 2024 and 2023, the performance share units (“PSUs”) granted to certain employees were not included in dilutive securities as the performance thresholds for vesting of the PSUs were not met as measured as of the respective periods.
IIP’s computation of FFO, Normalized FFO and AFFO may differ from the methodology for calculating FFO, Normalized FFO and AFFO utilized by other equity REITs and, accordingly, may not be comparable to such REITs. Further, FFO, Normalized FFO and AFFO do not represent cash flow available for management’s discretionary use. FFO, Normalized FFO and AFFO should not be considered as an alternative to net income (computed in accordance with GAAP) as an indicator of IIP’s financial performance or to cash flow from operating activities (computed in accordance with GAAP) as an indicator of IIP’s liquidity, nor is it indicative of funds available to fund IIP’s cash needs, including IIP’s ability to pay dividends or make distributions. FFO, Normalized FFO and AFFO should be considered only as supplements to net income computed in accordance with GAAP as measures of IIP’s operations.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250219562996/en/
Company Contact:
David Smith
Chief Financial Officer
Innovative Industrial Properties, Inc.
(858) 997-3332
Source: Innovative Industrial Properties, Inc.
FAQ
What was IIPR's revenue and earnings per share for full-year 2024?
How much did IIPR pay in dividends for 2024?
What is the current size of IIPR's property portfolio as of December 2024?
How did IIPR resolve the PharmaCann lease defaults in 2024?